JP2006525979A - シラニル−n−アルカナール化合物、その製造方法及びその使用 - Google Patents
シラニル−n−アルカナール化合物、その製造方法及びその使用 Download PDFInfo
- Publication number
- JP2006525979A JP2006525979A JP2006505821A JP2006505821A JP2006525979A JP 2006525979 A JP2006525979 A JP 2006525979A JP 2006505821 A JP2006505821 A JP 2006505821A JP 2006505821 A JP2006505821 A JP 2006505821A JP 2006525979 A JP2006525979 A JP 2006525979A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- solid support
- silanyl
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 77
- 238000000034 method Methods 0.000 title claims abstract description 20
- 230000008569 process Effects 0.000 title claims description 12
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 239000007787 solid Substances 0.000 claims abstract description 43
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 15
- 238000003786 synthesis reaction Methods 0.000 claims abstract description 12
- 239000013545 self-assembled monolayer Substances 0.000 claims description 17
- YOEOBPUCCSQUAJ-UHFFFAOYSA-N 11-silylundecanal Chemical compound [SiH3]CCCCCCCCCCC=O YOEOBPUCCSQUAJ-UHFFFAOYSA-N 0.000 claims description 13
- 150000001299 aldehydes Chemical group 0.000 claims description 11
- 239000003054 catalyst Substances 0.000 claims description 9
- 239000003638 chemical reducing agent Substances 0.000 claims description 9
- 239000002094 self assembled monolayer Substances 0.000 claims description 9
- 239000000126 substance Substances 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- 150000001412 amines Chemical group 0.000 claims description 7
- 239000003446 ligand Substances 0.000 claims description 6
- 108020004707 nucleic acids Proteins 0.000 claims description 6
- 150000007523 nucleic acids Chemical class 0.000 claims description 6
- 102000039446 nucleic acids Human genes 0.000 claims description 6
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims description 5
- 239000003960 organic solvent Substances 0.000 claims description 5
- QQQSFSZALRVCSZ-UHFFFAOYSA-N triethoxysilane Chemical compound CCO[SiH](OCC)OCC QQQSFSZALRVCSZ-UHFFFAOYSA-N 0.000 claims description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 230000003100 immobilizing effect Effects 0.000 claims description 4
- -1 lithium tetrahydroaluminate Chemical group 0.000 claims description 4
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 238000010992 reflux Methods 0.000 claims description 4
- PYQDABSJFOTHKA-UHFFFAOYSA-N 18-silyloctadecanal Chemical compound [SiH3]CCCCCCCCCCCCCCCCCC=O PYQDABSJFOTHKA-UHFFFAOYSA-N 0.000 claims description 3
- WBJINCZRORDGAQ-UHFFFAOYSA-N formic acid ethyl ester Natural products CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 claims description 3
- 239000007800 oxidant agent Substances 0.000 claims description 3
- 108090000623 proteins and genes Proteins 0.000 claims description 3
- 239000002356 single layer Substances 0.000 claims description 3
- GKASDNZWUGIAMG-UHFFFAOYSA-N triethyl orthoformate Chemical compound CCOC(OCC)OCC GKASDNZWUGIAMG-UHFFFAOYSA-N 0.000 claims description 3
- LESORDGPBBFSQA-UHFFFAOYSA-N 10-silyldecanal Chemical compound [SiH3]CCCCCCCCCC=O LESORDGPBBFSQA-UHFFFAOYSA-N 0.000 claims description 2
- MSQCDNIAJSTNMC-UHFFFAOYSA-N 12-silyldodecanal Chemical compound [SiH3]CCCCCCCCCCCC=O MSQCDNIAJSTNMC-UHFFFAOYSA-N 0.000 claims description 2
- QQDKIXPJMJWCGN-UHFFFAOYSA-N 14-silyltetradecanal Chemical compound [SiH3]CCCCCCCCCCCCCC=O QQDKIXPJMJWCGN-UHFFFAOYSA-N 0.000 claims description 2
- ZCDLTCBPSSOIEL-UHFFFAOYSA-N 15-silylpentadecanal Chemical compound [SiH3]CCCCCCCCCCCCCCC=O ZCDLTCBPSSOIEL-UHFFFAOYSA-N 0.000 claims description 2
- MCFZNJMZWWQEFV-UHFFFAOYSA-N 16-silylhexadecanal Chemical compound [SiH3]CCCCCCCCCCCCCCCC=O MCFZNJMZWWQEFV-UHFFFAOYSA-N 0.000 claims description 2
- VTPJIHYYQGAMRN-UHFFFAOYSA-N 8-silyloctanal Chemical compound [SiH3]CCCCCCCC=O VTPJIHYYQGAMRN-UHFFFAOYSA-N 0.000 claims description 2
- VMXOLNNZQQTFID-UHFFFAOYSA-N 9-silylnonanal Chemical compound [SiH3]CCCCCCCCC=O VMXOLNNZQQTFID-UHFFFAOYSA-N 0.000 claims description 2
- HTPHIGXFDBKJGN-UHFFFAOYSA-N [SiH3]CCCCCCCCCCCCC=O Chemical compound [SiH3]CCCCCCCCCCCCC=O HTPHIGXFDBKJGN-UHFFFAOYSA-N 0.000 claims description 2
- OFJHBJKUTGALSC-UHFFFAOYSA-N [SiH3]CCCCCCCCCCCCCCCCC=O Chemical compound [SiH3]CCCCCCCCCCCCCCCCC=O OFJHBJKUTGALSC-UHFFFAOYSA-N 0.000 claims description 2
- 150000001408 amides Chemical group 0.000 claims description 2
- 230000001413 cellular effect Effects 0.000 claims description 2
- 239000011521 glass Substances 0.000 claims description 2
- 229920003023 plastic Polymers 0.000 claims description 2
- 239000004033 plastic Substances 0.000 claims description 2
- 230000002194 synthesizing effect Effects 0.000 claims description 2
- 230000001225 therapeutic effect Effects 0.000 claims description 2
- JVZLQZNKYCCMGM-UHFFFAOYSA-N 19-silylnonadecanal Chemical compound [SiH3]CCCCCCCCCCCCCCCCCCC=O JVZLQZNKYCCMGM-UHFFFAOYSA-N 0.000 claims 1
- 239000000919 ceramic Substances 0.000 claims 1
- 238000007306 functionalization reaction Methods 0.000 abstract description 6
- 239000000243 solution Substances 0.000 description 20
- 108091034117 Oligonucleotide Proteins 0.000 description 11
- 125000000524 functional group Chemical group 0.000 description 11
- 229910052739 hydrogen Inorganic materials 0.000 description 11
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- 230000000295 complement effect Effects 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 7
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 7
- 239000007822 coupling agent Substances 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 150000004756 silanes Chemical class 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- 238000005481 NMR spectroscopy Methods 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- NMUOIBRAVXKEQL-UHFFFAOYSA-N 11,11-dimethoxyundec-1-ene Chemical compound COC(OC)CCCCCCCCC=C NMUOIBRAVXKEQL-UHFFFAOYSA-N 0.000 description 5
- 238000000018 DNA microarray Methods 0.000 description 5
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 5
- 150000001282 organosilanes Chemical class 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- JVDLQCPVJOUKJM-UHFFFAOYSA-N 11,11-dimethoxyundecylsilane Chemical compound COC(OC)CCCCCCCCCC[SiH3] JVDLQCPVJOUKJM-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical group ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 4
- 230000004913 activation Effects 0.000 description 4
- 125000003277 amino group Chemical group 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 229910000077 silane Inorganic materials 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 3
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000007795 chemical reaction product Substances 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 3
- 229910052753 mercury Inorganic materials 0.000 description 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 229910052710 silicon Inorganic materials 0.000 description 3
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000004630 atomic force microscopy Methods 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 125000003700 epoxy group Chemical group 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 150000003961 organosilicon compounds Chemical class 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- ZDHXKXAHOVTTAH-UHFFFAOYSA-N trichlorosilane Chemical compound Cl[SiH](Cl)Cl ZDHXKXAHOVTTAH-UHFFFAOYSA-N 0.000 description 2
- PANBRUWVURLWGY-UHFFFAOYSA-N 2-undecenal Chemical compound CCCCCCCCC=CC=O PANBRUWVURLWGY-UHFFFAOYSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000005046 Chlorosilane Substances 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 238000005411 Van der Waals force Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 238000005102 attenuated total reflection Methods 0.000 description 1
- 210000003050 axon Anatomy 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000012993 chemical processing Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- KOPOQZFJUQMUML-UHFFFAOYSA-N chlorosilane Chemical class Cl[SiH3] KOPOQZFJUQMUML-UHFFFAOYSA-N 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 150000004292 cyclic ethers Chemical class 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000000572 ellipsometry Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000005232 molecular self-assembly Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 239000002751 oligonucleotide probe Substances 0.000 description 1
- 229920000620 organic polymer Polymers 0.000 description 1
- 239000011224 oxide ceramic Substances 0.000 description 1
- 229910052574 oxide ceramic Inorganic materials 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- SCPYDCQAZCOKTP-UHFFFAOYSA-N silanol Chemical compound [SiH3]O SCPYDCQAZCOKTP-UHFFFAOYSA-N 0.000 description 1
- 239000002210 silicon-based material Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000003746 surface roughness Effects 0.000 description 1
- WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
- 239000005052 trichlorosilane Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0896—Compounds with a Si-H linkage
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y40/00—Manufacture or treatment of nanostructures
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- General Physics & Mathematics (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Nanotechnology (AREA)
- Food Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Composite Materials (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Materials Engineering (AREA)
- Manufacturing & Machinery (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Description
CH(O)−CnH2n−SiH3 (I)
ここで、nは7と20の間に含まれる、そして、好ましくは11と18の間に含まれる整数を表す。
(i)第一段階において、以下の式(II)の化合物:
(ここで、nは式(II)の化合物に関する上の記載と同じ意味を有する);
ii)第2段階において、第1段階で得た式(III)の化合物を、触媒存在下でトリエトキシシランの溶液中で反応させ、以下の式(IV)の化合物を得:
iii)第3段階において、上記の式(IV)の化合物により保有されるエトキシ基のみを、無水溶媒の溶液中及び穏やかな還元剤の存在下で還元し、以下の式(V)の化合物を得:
iv)そして、第4段階において、上記の式(V)の化合物を有機溶媒の溶液中及び酸化剤存在下で酸化し、式(I)に対応する化合物を得る:
ことを特徴とする。
これは、幾分弱い還元剤(水素化ホウ素ナトリウムのような)は、式(IV)の化合物により保有されるエトキシ基を還元できないためであり、一方、より強い還元剤(リチウムトリヒドロアルミナートのような)は、エトキシ基の還元だけでなく、式(IV)の化合物のメトキシ基も還元し、従って、第4段階におけるアルデヒド官能基の引き続く形成を妨げる。
約2〜10℃の温度で、約12から24時間、有機溶媒(例えば、トリクロロエチレンのような)中の本発明に従う式(I)の少なくとも一つの化合物の溶液に接触させることによる当業者にとって従来の方法で調製し得る。基板は、続いて様々な溶媒、好ましくは及び連続的にはトリクロロエチレン、エタノール、クロロホルム及びペンタン、で洗浄し、そして、好ましくは窒素で乾燥させる。
− 11−シラニルウンデカナールをケイ質支持体の表面にグラフトさせ、オリゴヌクレオチドをグラフトさせ(手動で付着させる)、そして、相補的なターゲットとハイブリダイゼーションさせた後にエピ蛍光顕微鏡において得られた蛍光の写真を図1に示し;
− 11−シラニルウンデカナールをケイ質支持体の表面にグラフトさせ、オリゴヌクレオチドをグラフトさせ(自動デバイスを使用して付着させる)、そして、相補的なターゲットとハイブリダイゼーションさせた後にスキャナー上で得られた蛍光の写真を図2に示す。
1)第1段階:11,11−ジメトキシウンデク−1−エン(7)の合成
δH(200MHz、CDCl3):1.31(12H、m、H4−9)、1.59(2H、m、H10)、2.06(2H、m、H3)、3.21(6H、s、H12+13)、4.38(1H、t、H11、3JH−H 5.7Hz)、4.98(2H、m、H1)、5.81(1H、m、H2)、δC(200MHz、CDCl3):24.97、29.30、29.48、29.76、29.84、29.87、32.87、34.18、52.91(C12+13)、104.94(C11)、114.48(C1)、139.54(C2)、m/z(NBA):213[M−H]+。
δH(200MHz、CDCl3):0.59(2H、m、H13)、1.19(9H、t、H15、3JH−H 7Hz)、1.22(16H、m、H5−12)、1.53(2H、m、H4)、3.27(6H、s、H1+2)、3.76(6H、q、H14、3JH−H 7Hz)、4.32(1H、t、H3、3JH−H 5.7Hz)、δC(200MHz、CDCl3):10.70(C13)、18.60(C15)、23.08、24.93、29.56、29.82、29.88、32.80、33.49、33.49、52.79(C1+2)、58.56(C14)、104.86(C3)、δSi(200MHz、CDCl3):−44.23、m/z(NBA):377[M−H]+。
NMR: δH(200MHz、CDCl3):0.78(2H、m、H13)、1.30(16H、m、H5−12)、1.64(2H、m、H4)、3.36(6H、s、H1+2)、3.51(3H、t、H14、3JH−H 3.9Hz)、4.39(1H、t、H3、3JH−H 5.7Hz)、δC(200MHz、CDCl3):6.28(C13)、24.98,26.73,29.62,29.85,29.92,29.98,32.83,32.86,52.81(C1+2)、104.87(C3)、δSi(200MHz、CDCl3):−58.93;
IR:1056.7 and 1125.7(CO)、2149.2(SiH3)、2854(s CH2)、2924(as CH2)、m/z(NBA):245[M−H]+。
NMR:δH(200MHz、CDCl3):0.73(2H、m、H1)、1.27(16H、m、H4−10)、1.61(2H、m、H3)、2.41(2H、td、H2、3JH−H1 3.9Hz、3JH−H1 7.4Hz)3.47(3H、t、H12、3JH−H 3.9Hz)、9.75(1H、t、H1、3JH−H 1.9Hz)、δC(200MHz、CDCl3):6.30(C11)、22.47,26.73,29.60,29.63,29.88,29.94,32.85,32.87,44.30(C2)、203.33(C1)、δSi(200MHz、CDCl3):−58.97;
IR:1728(C=O)、2149(SiH3)、2714(CHO)、2854(s CH2)、2924(as CH2)、m/z(NBA):199[M−H]+。
この例において、上記の実施例1で調製された11−シラニルウンデカナールを式(I)の化合物として使用する。
この例において、上記の実施例2で調製した修飾された固体支持体を使用する。
配列番号2は、配列番号1のプローブがハイブリダイズするオリゴヌクレオチドの塩基配列を示す。
Claims (13)
- 以下の式(I):
CH(O)−CnH2n−SiH3 (I)
ここで、nは7と20の間に含まれる整数を示す、
に対応することを特徴とするω−シラニル−n−アルカナール化合物。 - nが11と18の間に含まれることを特徴とする請求項1に記載の化合物。
- 8−シラニルオクタナール、9−シラニルノナナール、10−シラニルデカナール、11−シラニルウンデカナール、12−シラニルドデカナール、13−シラニルトリデカナール、14−シラニルテトラデカナール、15−シラニルペンタデカナール、16−シラニルヘキサデカナール、17−シラニルヘプタデカナール、18−シラニルオクタデカナール、19−シラニルノナデカナール及び20−シラニルドデカナールから選択されることを特徴とする請求項1に記載の化合物。
- (i)第1段階において、以下の式(II)の化合物:
ii)第2段階において、第1段階で得た式(III)の化合物を、触媒存在下でトリエトキシシランの溶液中で反応させ、以下の式(IV)の化合物を得:
iii)第3段階において、上記の式(IV)の化合物により保有されるエトキシ基のみを、無水溶媒の溶液中及び穏やかな還元剤の存在下で還元し、以下の式(V)の化合物を得:
iv)そして、第4段階において、上記の式(V)の化合物を有機溶媒の溶液中及び酸化剤存在下で酸化し、式(I)に対応する化合物を得る:
ことを特徴とする、請求項1から3のいずれかに記載の式(I)の化合物の製造方法。 - 第3段階中に使用される穏やかな還元剤が、リチウムテトラヒドロアルミナートであることを特徴とする請求項4に記載のプロセス。
- ヒドロキシル官能基を含有する固体支持体の表面において、配列した自己組織化単分子膜を形成する請求項1から3のいずれかに記載の式(I)の少なくとも一つの化合物の使用。
- 少なくとも一つの表面が配列した自己組織化単分子膜により修飾される固体支持体において、前記単分子膜が請求項1から3のいずれかに記載の式(I)の少なくとも一つの化合物のネットワークを含むことを特徴とする固体支持体。
- ガラス、酸化物型のセラミックス及びプラスチックからなる群から選択されることを特徴とする請求項7に記載の固体支持体。
- アミン官能基を含む有利な生物学的または化学的分子の共有結合経路による合成または固定化のための請求項7または8に記載の固体支持体の使用。
- 前記分子が、核酸、タンパク質、細胞リガンド、治療標的分子及びコンビナトリアルケミストリーリガンドの中から選択されることを特徴とする請求項9に記載の使用。
- 請求項7または8に記載の固体支持体上における分子の合成方法であって、前記分子が一連の繰り返し単位から構成され、及び、前記方法が前記繰り返し単位にグラフトする連続的な段階を含むことを特徴とし、グラフトされた第1の繰り返し単位が、該固体上に存在しかつ請求項1から3のいずれかに記載の式(I)の化合物のアルデヒド官能基に関して反応性であるアミン官能基を保有する、方法。
- 請求項1から3のいずれかに記載の式(I)の化合物のアルデヒド官能基に関して反応性であるアミン官能基を保有する前記生体分子を固体支持体にグラフトする段階を含むことを特徴とする、請求項7または8に記載の固体支持体に生体分子を固定化する方法。
- 生物学的または化学的分子がアミド官能基を介して共有結合的に固定化される請求項7または8に記載の固体支持体。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR03/05391 | 2003-04-30 | ||
FR0305391A FR2854400B1 (fr) | 2003-04-30 | 2003-04-30 | COMPOSES SILANYL-n ALCANAL, LEUR PROCEDE DE PREPARATION ET LEURS UTILISATIONS |
PCT/FR2004/001030 WO2004099219A2 (fr) | 2003-04-30 | 2004-04-28 | Composes silanyl-n alcanal, leur procede de preparation et leurs utilisations |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2006525979A true JP2006525979A (ja) | 2006-11-16 |
JP4781261B2 JP4781261B2 (ja) | 2011-09-28 |
Family
ID=33155602
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006505821A Expired - Fee Related JP4781261B2 (ja) | 2003-04-30 | 2004-04-28 | シラニル−n−アルカナール化合物、その製造方法及びその使用 |
Country Status (5)
Country | Link |
---|---|
US (1) | US7442823B2 (ja) |
EP (1) | EP1626977A2 (ja) |
JP (1) | JP4781261B2 (ja) |
FR (1) | FR2854400B1 (ja) |
WO (1) | WO2004099219A2 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012520912A (ja) * | 2009-03-18 | 2012-09-10 | ビーエーエスエフ ソシエタス・ヨーロピア | 修飾シリカ粒子およびそれらを含む防塵ポリマー組成物 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002051856A2 (fr) * | 2000-12-22 | 2002-07-04 | Commissariat A L'energie Atomique | Procede d'immobilisation de sondes, en particulier pour realiser des puces biologiques |
-
2003
- 2003-04-30 FR FR0305391A patent/FR2854400B1/fr not_active Expired - Fee Related
-
2004
- 2004-04-28 EP EP04742596A patent/EP1626977A2/fr not_active Withdrawn
- 2004-04-28 JP JP2006505821A patent/JP4781261B2/ja not_active Expired - Fee Related
- 2004-04-28 WO PCT/FR2004/001030 patent/WO2004099219A2/fr active Application Filing
- 2004-04-28 US US10/554,742 patent/US7442823B2/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002051856A2 (fr) * | 2000-12-22 | 2002-07-04 | Commissariat A L'energie Atomique | Procede d'immobilisation de sondes, en particulier pour realiser des puces biologiques |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012520912A (ja) * | 2009-03-18 | 2012-09-10 | ビーエーエスエフ ソシエタス・ヨーロピア | 修飾シリカ粒子およびそれらを含む防塵ポリマー組成物 |
Also Published As
Publication number | Publication date |
---|---|
US20070032672A1 (en) | 2007-02-08 |
FR2854400A1 (fr) | 2004-11-05 |
WO2004099219A2 (fr) | 2004-11-18 |
JP4781261B2 (ja) | 2011-09-28 |
EP1626977A2 (fr) | 2006-02-22 |
US7442823B2 (en) | 2008-10-28 |
WO2004099219A3 (fr) | 2005-12-01 |
FR2854400B1 (fr) | 2007-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1607743B1 (en) | Silane molecules with pre-activated and protein-resistant functionalities and silane films comprising such molecules | |
US6824866B1 (en) | Porous silica substrates for polymer synthesis and assays | |
US20050277155A1 (en) | Method of immobilizing probes, in particular for producing biochips | |
JP2001520396A (ja) | オリゴヌクレオチド単分子層の高表面密度共有結合固定化 | |
FR2896802A1 (fr) | Nouveaux composes silanes et leur utilisation pour fonctionnaliser des supports solides et immobiliser sur ces supports de molecules biologiques | |
Phaner-Goutorbe et al. | Silanization of silica and glass slides for DNA microarrays by impregnation and gas phase protocols: A comparative study | |
WO2000061282A1 (en) | Porous silica substrates for polymers synthesis and assays | |
EP1798250B1 (en) | Molecules suitable for binding to a metal layer for covalently immobilizing biomolecules | |
JP2004506922A (ja) | バイオチップマイクロアレイを構築するための固体支持体の表面活性化を得る方法 | |
AU2004272465B2 (en) | Size-controlled macromolecule | |
EP1176423B1 (en) | Surface-attached polyfunctional polymer networks for sensor chips | |
JP2007186472A (ja) | 光分解性カップリング剤 | |
US20030129740A1 (en) | Method of preparing substrate having functional group pattern for immobilizing physiological material | |
JP4781261B2 (ja) | シラニル−n−アルカナール化合物、その製造方法及びその使用 | |
US20030044798A1 (en) | Methods for generating ligand arrays via deposition of ligands onto olefin displaying substrates, and arrays produced thereby | |
JP2005528583A (ja) | 接着方法 | |
US7718577B2 (en) | Linker compound, substrate coated with the compound, method of producing microarray using the compound and microarray produced by the method | |
JP3933979B2 (ja) | 表面修飾された多孔性シリカおよびその製造方法 | |
JP4150201B2 (ja) | 遺伝子チップの調製方法 | |
FR2842826A1 (fr) | Procede de fabrication de puces biologiques | |
JPH07188259A (ja) | シランとその使用方法 | |
JP5220000B2 (ja) | 固体支持体の官能化及びこれら支持体上への生物学的分子の固定化のための、ヒドラゾンもしくはジアゾ官能基を担持する新規なシラン化合物 | |
Joly et al. | Hybrid Bioorganic–Inorganic Materials Prepared by Site‐Specific Ligation of Peptides to Functionalized Polydisperse Silica Particles | |
KR20030005652A (ko) | 실리케이트의 코팅 방법 | |
Eritja Casadellà et al. | Fabrication of patterned surfaces by photolithographic exposure of dna hairpins carrying a novel photolabile group |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070406 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100421 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100714 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20110607 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20110705 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140715 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |